LAB
Standard BioTools Inc. · Healthcare
Casdin Partners Master Fund, L.P. bought $10.1M of Standard BioTools Inc.
Director and 10% owner
Bought$10,053,280
$1.31Price
7,700,000Shares
+9%Stake
What LAB did for a copier
- $1,000 copied at Wed, Nov 26 close, $1.43
- $1,056
- S&P 500, same days
- +3.1%
Measured over 30 trading days, to the Jan 12 close.
Casdin Partners Master Fund, L.P.'s record
18 other buys with 3 months of prices since 2020: on average −8.5% against the S&P 500, and 7 of 18 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Nov 24. Filed Wed, Nov 26, 11:58 AM ET, during the session. Returns use the Nov 26 close and the Jan 12 close. Not investment advice.